Literature DB >> 23845414

T2-*weighted perfusion MRI.

E L Barbier1.   

Abstract

T2*-weighted perfusion MRI is based on the so-called "first passage" approach: the modifications in the T2-weighted MRI signal are followed during the first passage of a bolus of contrast agent. The pixel-by-pixel analysis of the curves is used to obtain parametric maps (time of arrival, time of the peak, mean transit time, relative volume and blood flow). Further analysis, with deconvolution by arterial input function (concentration of contrast agent in the blood), helps improve the quantification. It is possible to pre-inject a small dose of contrast agent to limit the impact of the extravasation of the contrast agent.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Keywords:  Blood flow; Blood volume; Imaging; Mean transit time; Perfusion

Mesh:

Substances:

Year:  2013        PMID: 23845414     DOI: 10.1016/j.diii.2013.06.007

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  3 in total

Review 1.  State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications.

Authors:  Magalie Viallon; Victor Cuvinciuc; Benedicte Delattre; Laura Merlini; Isabelle Barnaure-Nachbar; Seema Toso-Patel; Minerva Becker; Karl-Olof Lovblad; Sven Haller
Journal:  Neuroradiology       Date:  2015-04-10       Impact factor: 2.804

2.  Quantitative MR Perfusion for the Differentiation of Recurrence and Radionecrosis in Hypoperfusion and Hyperperfusion Brain Metastases After Gamma Knife Radiosurgery.

Authors:  Yang Yunqi; Niu Aihua; Zheng Zhiming; Liu Yingchao; Wang Qiang; Ming Yang; Zhang Yi
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

3.  Regional 18F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma.

Authors:  Jianhua Qin; Yu Tang; Bao Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.